Mid-market focus Kalo Clinical Research is a privately owned, small to mid-sized CRO with 11-50 employees operating in Salt Lake City. This profile suggests opportunities to upsell scalable, cost-effective CRO services, ongoing project support, and flexible partnerships tailored to mid-sized pharmaceutical teams and niche clinical programs.

Therapeutic breadth The firm conducts trials in diabetes, high blood pressure, and other areas, indicating potential for expanding service offerings in cardiovascular and metabolic disease trials, as well as diabetes management endpoints, patient recruitment strategies, and data management capabilities.

Tech-enabled Utilizes a mix of marketing analytics and cloud-based tools (DoubleClick Floodlight, Google Cloud CDN, Office 365) alongside practice/booking software (Sirvoy). This suggests opportunities to propose integrated trial operations solutions, digital recruitment optimization, and secure data collaboration platforms.

Healthy growth signals Revenue is in the $1M-$10M range with several comparable CROs of significantly larger scale. This implies potential for strategic partnerships, co-development of specialized trial services, or bundled offerings to gain scale while maintaining personalized service.

Local advantage Located within Salt Lake Regional Medical Center in Utah, there is a chance to pursue regional site network collaborations, access to patient populations, and leveraging local clinical infrastructure for faster patient enrollment and expedited study timelines in the western U.S.